Compugen reported an initial statement of beneficial ownership filed by Sharon Kredo Russo, an officer serving as SVP, Research and Discovery. The filing listed 19,500 ordinary shares beneficially owned directly. It also reported a share option for 26,000 ordinary shares with an exercise price of USD 1.64.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compugen Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-000959), on March 18, 2026, and is solely responsible for the information contained therein.
Comments